SULPIRIDE TEVA 50 mg, hard capsule 30 capsules
Active ingredients: SULPIRIDE
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule30 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SULPIRIDE TEVA 50 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVDC PVC-Aluminium de 30 gélule(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Jun 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61055303CIP73614317CIP133400936143173Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULPIRIDEgélule | 50,00 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: SULPIRIDE 50 mg - DOGMATIL 50 mg, gélule